Hongsen Investment
Hongsen Investment Group is a venture capital firm established in 2020 and located in Hong Kong. The firm specializes in investing in the pharmaceutical and biotech sectors, focusing on emerging companies that demonstrate innovative potential within these industries. By providing financial support and strategic guidance, Hongsen aims to foster the growth of promising ventures that can contribute to advancements in healthcare and biotechnology.
1 past transactions
Abcuro
Series A in 2021
Abcuro develops immunotherapies targeting autoimmunity and cancer. Founded in 2015, the company uses bioinformatics and ex-vivo validation to uncover novel immune system targets.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.